Literature DB >> 19996313

Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the Co-chaperone p23.

Ahmed Chadli1, Sara J Felts2, Qin Wang3, William P Sullivan2, Maria Victoria Botuyan2, Abdul Fauq4, Marina Ramirez-Alvarado2, Georges Mer2.   

Abstract

Hsp90 is an ATP-dependent molecular chaperone. The best characterized inhibitors of Hsp90 target its ATP binding pocket, causing nonselective degradation of Hsp90 client proteins. Here, we show that the small molecule celastrol inhibits the Hsp90 chaperoning machinery by inactivating the co-chaperone p23, resulting in a more selective destabilization of steroid receptors compared with kinase clients. Our in vitro and in vivo results demonstrate that celastrol disrupts p23 function by altering its three-dimensional structure, leading to rapid formation of amyloid-like fibrils. This study reveals a unique inhibition mechanism of p23 by a small molecule that could be exploited in the dissection of protein fibrillization processes as well as in the therapeutics of steroid receptor-dependent diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996313      PMCID: PMC2823561          DOI: 10.1074/jbc.M109.081018

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol.

Authors:  Sridhar Sreeramulu; Santosh Lakshmi Gande; Michael Göbel; Harald Schwalbe
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  Molecular chaperone machines: chaperone activities of the cyclophilin Cyp-40 and the steroid aporeceptor-associated protein p23.

Authors:  B C Freeman; D O Toft; R I Morimoto
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

3.  Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.

Authors:  Haley Hieronymus; Justin Lamb; Kenneth N Ross; Xiao P Peng; Cristina Clement; Anna Rodina; Maria Nieto; Jinyan Du; Kimberly Stegmaier; Srilakshmi M Raj; Katherine N Maloney; Jon Clardy; William C Hahn; Gabriela Chiosis; Todd R Golub
Journal:  Cancer Cell       Date:  2006-09-28       Impact factor: 31.743

4.  Tripterine inhibits the expression of adhesion molecules in activated endothelial cells.

Authors:  Deng-hai Zhang; Anthony Marconi; Li-min Xu; Chun-xin Yang; Guo-wu Sun; Xiao-ling Feng; Chang-quan Ling; Wan-zhang Qin; Georges Uzan; Patrizia d'Alessio
Journal:  J Leukoc Biol       Date:  2006-06-12       Impact factor: 4.962

Review 5.  Heat shock proteins and cardiac protection.

Authors:  D S Latchman
Journal:  Cardiovasc Res       Date:  2001-09       Impact factor: 10.787

Review 6.  Therapeutic strategies for human amyloid diseases.

Authors:  James C Sacchettini; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

7.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

Review 8.  Discovery and development of heat shock protein 90 inhibitors.

Authors:  Tony Taldone; Weilin Sun; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2008-11-06       Impact factor: 3.641

9.  Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule.

Authors:  Amy Trott; James D West; Lada Klaić; Sandy D Westerheide; Richard B Silverman; Richard I Morimoto; Kevin A Morano
Journal:  Mol Biol Cell       Date:  2008-01-16       Impact factor: 4.138

10.  Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis.

Authors:  Ting-Wei Mu; Douglas M Fowler; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2008-02       Impact factor: 8.029

View more
  39 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

Review 3.  Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

Authors:  Gaurav Garg; Anuj Khandelwal; Brian S J Blagg
Journal:  Adv Cancer Res       Date:  2016-02-10       Impact factor: 6.242

4.  Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.

Authors:  Chaitanya A Patwardhan; Abdul Fauq; Laura B Peterson; Charles Miller; Brian S J Blagg; Ahmed Chadli
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

5.  Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets.

Authors:  Lada Klaić; Richard I Morimoto; Richard B Silverman
Journal:  ACS Chem Biol       Date:  2012-03-14       Impact factor: 5.100

6.  Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way.

Authors:  Denghai Zhang; Limin Xu; Fanfan Cao; Tingxuan Wei; Chunxin Yang; Georges Uzan; Bin Peng
Journal:  Cell Stress Chaperones       Date:  2010-05-18       Impact factor: 3.667

Review 7.  Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.

Authors:  Laura J Blair; Jonathan J Sabbagh; Chad A Dickey
Journal:  Expert Opin Ther Targets       Date:  2014-07-29       Impact factor: 6.902

Review 8.  Heat shock protein 90: its inhibition and function.

Authors:  Abbey D Zuehlke; Michael A Moses; Len Neckers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

9.  Management of Hsp90-Dependent Protein Folding by Small Molecules Targeting the Aha1 Co-Chaperone.

Authors:  Jay K Singh; Darren M Hutt; Bradley Tait; Naihsuan C Guy; Jeffrey C Sivils; Nina R Ortiz; Ashley N Payan; Shravan Kumar Komaragiri; Jazzmin Jovonna Owens; David Culbertson; Laura J Blair; Chad Dickey; Szu Yu Kuo; Dan Finley; H Jane Dyson; Marc B Cox; Jaideep Chaudhary; Jason E Gestwicki; William E Balch
Journal:  Cell Chem Biol       Date:  2020-02-03       Impact factor: 8.116

10.  Bioactive metabolites from Chaetomium aureum: structure elucidation and inhibition of the Hsp90 machine chaperoning activity.

Authors:  Fatima Zahra Kabbaj; Su Lu; My El Abbés Faouzi; Bouchra Meddah; Peter Proksch; Yahya Cherrah; Hans-Josef Altenbach; Amal H Aly; Ahmed Chadli; Abdessamad Debbab
Journal:  Bioorg Med Chem       Date:  2014-11-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.